Drug-HPMA-HuIg conjugates effective against human solid cancer.
Ríhová
Blanka
B
Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídenská 1083, 142 20 Prague 4, Czech Republic.
Strohalm
Jirí
J
Kubácková
Katerina
K
Jelínková
Markéta
M
Rozprimová
Ladka
L
Sírová
Milada
M
Plocová
Dana
D
Mrkvan
Tomás
T
Kovár
Marek
M
Pokorná
Jindriska
J
Etrych
Tomás
T
Ulbrich
Karel
K
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000628:therapy; D004317:Doxorubicin / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D005260:Female; D006338:Heart Neoplasms / Q000188:drug therapy / Q000628:therapy; D016027:Heart Transplantation; D006394:Hemangiosarcoma / Q000188:drug therapy / Q000628:therapy; D006492:Hempa / Q000138:chemical synthesis / Q000737:chemistry*; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D007167:Immunotherapy; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D015251:Epirubicin; D004317:Doxorubicin; D006492:Hempa